• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心律失常性心肌病患者运动强度和运动时间的有害影响。

Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.

机构信息

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Center for Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Center for Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

出版信息

JACC Clin Electrophysiol. 2018 Jun;4(6):744-753. doi: 10.1016/j.jacep.2018.01.010. Epub 2018 Mar 28.

DOI:10.1016/j.jacep.2018.01.010
PMID:29929667
Abstract

OBJECTIVES

The goal of this study was to explore the association between exercise duration versus exercise intensity and adverse outcome in patients with arrhythmogenic cardiomyopathy (AC).

BACKGROUND

Vigorous exercise aggravates and accelerates AC, but there are no data assessing the harmful effects of exercise intensity and duration in these patients.

METHODS

Exercise habits at time of diagnosis were recorded by standardized interviews in consecutive AC patients. Exercise >6 metabolic equivalents was defined as high intensity, and exercise duration was categorized as long if above median. Life-threatening ventricular arrhythmia (VA) was defined as aborted cardiac arrest, documented sustained ventricular tachycardia, ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy.

RESULTS

We included 173 AC patients (53% probands; 44% female; 41 ± 16 years of age). Median weekly exercise duration was 2.5 h (interquartile range: 2.0 to 5.5 h), and 91 patients (52%) reported high-intensity exercise. VA had occurred in 83 patients (48%) and was more prevalent in patients with high-intensity exercise than low-intensity exercise (74% vs. 20%, p < 0.001), and more prevalent in long-duration than short-duration exercise (65% vs. 31%, p < 0.001). High-intensity exercise was a strong and independent marker of VA, even when adjusted for the interaction with long-duration exercise (odds ratio: 3.8; 95% confidence interval: 1.3 to 11.0, p < 0.001), whereas long-duration exercise was not.

CONCLUSIONS

High-intensity exercise was a strong and independent marker of life-threatening VA in AC patients, independent of exercise duration. AC patients could be advised to restrict their exercise intensity.

摘要

目的

本研究旨在探讨心律失常性心肌病(AC)患者运动时间与运动强度与不良结局的关系。

背景

剧烈运动可加重和加速 AC,但尚无数据评估这些患者运动强度和时间的有害影响。

方法

通过对连续 AC 患者进行标准化访谈,记录诊断时的运动习惯。运动 >6 代谢当量定义为高强度,运动时间超过中位数为长。危及生命的室性心律失常(VA)定义为心脏骤停、记录到持续性室性心动过速、心室颤动或适当的植入式心脏复律除颤器治疗。

结果

共纳入 173 例 AC 患者(53%为先证者;44%为女性;41 ± 16 岁)。每周运动时间中位数为 2.5 小时(四分位间距:2.0 至 5.5 小时),91 例患者(52%)报告高强度运动。83 例患者(48%)发生 VA,高强度运动患者比低强度运动患者更常见(74%比 20%,p<0.001),长时间运动患者比短时间运动患者更常见(65%比 31%,p<0.001)。高强度运动是 VA 的一个强烈而独立的标志物,即使在调整与长时间运动的相互作用后也是如此(优势比:3.8;95%置信区间:1.3 至 11.0,p<0.001),而长时间运动则不是。

结论

高强度运动是 AC 患者发生危及生命的 VA 的一个强烈且独立的标志物,与运动时间无关。可以建议 AC 患者限制其运动强度。

相似文献

1
Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.心律失常性心肌病患者运动强度和运动时间的有害影响。
JACC Clin Electrophysiol. 2018 Jun;4(6):744-753. doi: 10.1016/j.jacep.2018.01.010. Epub 2018 Mar 28.
2
Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study.致心律失常性右室心肌病患者发生威胁生命的室性心律失常的预测:一项一级预防队列研究。
JACC Cardiovasc Imaging. 2018 Oct;11(10):1377-1386. doi: 10.1016/j.jcmg.2018.05.017. Epub 2018 Jul 18.
3
Life-threatening arrhythmic presentation in patients with arrhythmogenic cardiomyopathy before and after entering the genomic era; a two-decade experience from a large volume center.致心律失常性右室心肌病患者在基因组时代前后出现危及生命的心律失常表现:大容量中心二十年的经验。
Int J Cardiol. 2019 Mar 15;279:79-83. doi: 10.1016/j.ijcard.2018.12.066. Epub 2018 Dec 27.
4
Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis.致心律失常性右室心肌病的左心室功能障碍:与运动暴露、遗传基础和预后的关系。
J Am Heart Assoc. 2021 Apr 20;10(8):e018680. doi: 10.1161/JAHA.120.018680. Epub 2021 Apr 6.
5
Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy.致心律失常性右室心肌病患者疾病进展和心律失常风险的性别差异。
Europace. 2021 Jul 18;23(7):1084-1091. doi: 10.1093/europace/euab077.
6
Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular Arrhythmias.致心律失常性右室心肌病的右心室功能异常:与危及生命的室性心律失常的关系。
JACC Cardiovasc Imaging. 2021 May;14(5):900-910. doi: 10.1016/j.jcmg.2020.12.028. Epub 2021 Feb 10.
7
Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers.美国心脏协会推荐的最小运动量对桥粒突变携带者的安全性。
Heart Rhythm. 2016 Jan;13(1):199-207. doi: 10.1016/j.hrthm.2015.08.035. Epub 2015 Aug 29.
8
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.致心律失常性右室心肌病/发育不良患者的风险分层,无需植入式心脏复律除颤器。
JACC Clin Electrophysiol. 2018 Jun;4(6):757-768. doi: 10.1016/j.jacep.2018.04.017.
9
Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome.超声心动图评估心律失常性右室心肌病/发育不良的左心室受累可预测不良临床转归。
J Am Soc Echocardiogr. 2015 Sep;28(9):1103-13.e9. doi: 10.1016/j.echo.2015.04.015. Epub 2015 May 27.
10
Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.2015 年国际工作组共识声明风险分层算法在致心律失常性右室心肌病/发育不良中的植入式心脏复律除颤器放置中的表现。
Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005593. doi: 10.1161/CIRCEP.117.005593. Epub 2018 Feb 16.

引用本文的文献

1
Exercise Prescription in Arrhythmogenic Cardiomyopathy: Finding the Right Balance Between Risks and Benefits.致心律失常性心肌病的运动处方:在风险与益处之间找到恰当平衡
J Am Heart Assoc. 2025 Jun 17;14(12):e039125. doi: 10.1161/JAHA.124.039125. Epub 2025 Jun 5.
2
Sudden cardiac death in congenital heart disease-a narrative review and update.先天性心脏病中的心脏性猝死——一篇叙述性综述及更新
Front Cardiovasc Med. 2025 Apr 30;12:1539958. doi: 10.3389/fcvm.2025.1539958. eCollection 2025.
3
Arrhythmogenic Cardiomyopathy -Related: Clinical and Functional Characterization of a Pathogenic Variant Detected in Two Italian Families.
致心律失常性心肌病相关:在两个意大利家庭中检测到的一种致病变异的临床和功能特征
Genes (Basel). 2025 Mar 31;16(4):419. doi: 10.3390/genes16040419.
4
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常运动员参与竞技运动的临床考量:美国心脏协会和美国心脏病学会的科学声明
J Am Coll Cardiol. 2025 Mar 18;85(10):1059-1108. doi: 10.1016/j.jacc.2024.12.025. Epub 2025 Feb 20.
5
Naxos Disease and Related Cardio-Cutaneous Syndromes.纳克索斯病及相关的心皮综合征
JACC Adv. 2025 Jan 10;4(2):101547. doi: 10.1016/j.jacadv.2024.101547. eCollection 2025 Feb.
6
Progression of myocardial dysfunction and prediction of arrhythmic events in patients with exercise-induced arrhythmogenic cardiomyopathy.运动诱发的致心律失常性心肌病患者心肌功能障碍的进展及心律失常事件的预测
Heart Rhythm O2. 2024 Aug 10;5(10):705-712. doi: 10.1016/j.hroo.2024.08.003. eCollection 2024 Oct.
7
Lifetime cumulative activity burden is associated with symptomatic heart failure and arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy: a retrospective cohort study.终身累计活动负担与致心律失常性右心室心肌病患者的症状性心力衰竭和心律失常风险相关:一项回顾性队列研究。
Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae236.
8
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug.
9
Arrhythmogenic Cardiomyopathy: Current Updates and Future Challenges.致心律失常性心肌病:当前进展与未来挑战
Rev Cardiovasc Med. 2024 Jun 4;25(6):208. doi: 10.31083/j.rcm2506208. eCollection 2024 Jun.
10
Navigating the penetrance and phenotypic spectrum of inherited cardiomyopathies.遗传性心肌病的外显率和表型谱分析。
Heart Fail Rev. 2024 Sep;29(5):873-881. doi: 10.1007/s10741-024-10405-x. Epub 2024 Jun 19.